TCIM
AST.WS

TIAA CREF Investment Management’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

TIAA CREF Investment Management’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-153
Closed – – 3149
2017
Q2 		$0 Hold
153
– – ﹤0.01% 3277
2017
Q1 		$0 Hold
153
– – ﹤0.01% 3143
2016
Q4 		$0 Hold
153
– – ﹤0.01% 3164
2016
Q3 		$0 Sell
153
-186
-55% -$51 ﹤0.01% 3171
2016
Q2 		$0 Buy
+339
New +$177 ﹤0.01% 3290

TIAA CREF Investment Management's AST.WS Position: Q3 2017 in Review

TIAA CREF Investment Management sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 153 shares.

TIAA CREF Investment Management first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • TIAA CREF Investment Management reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 153 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
  • TIAA CREF Investment Management first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • TIAA CREF Investment Management's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on TIAA CREF Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.